Arrowstreet Capital Limited Partnership Has $7.15 Million Stake in TriMas Corporation $TRS

Arrowstreet Capital Limited Partnership increased its position in shares of TriMas Corporation (NASDAQ:TRS) by 197.5% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 249,929 shares of the industrial products company’s stock after buying an additional 165,925 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in TriMas were worth $7,150,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Pzena Investment Management LLC raised its position in shares of TriMas by 2.0% during the second quarter. Pzena Investment Management LLC now owns 2,177,761 shares of the industrial products company’s stock worth $62,306,000 after purchasing an additional 42,207 shares during the period. Irenic Capital Management LP purchased a new stake in TriMas during the 1st quarter worth about $19,997,000. Alta Fox Capital Management LLC bought a new position in TriMas in the 1st quarter valued at $17,385,000. Charles Schwab Investment Management Inc. raised its holdings in shares of TriMas by 1.4% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 614,023 shares of the industrial products company’s stock valued at $14,387,000 after acquiring an additional 8,521 shares in the last quarter. Finally, Loomis Sayles & Co. L P increased its position in shares of TriMas by 42.5% in the second quarter. Loomis Sayles & Co. L P now owns 396,533 shares of the industrial products company’s stock worth $11,345,000 after purchasing an additional 118,313 shares during the last quarter. 99.42% of the stock is owned by institutional investors and hedge funds.

TriMas Stock Performance

Shares of TriMas stock opened at $33.90 on Thursday. TriMas Corporation has a 12 month low of $19.33 and a 12 month high of $40.34. The firm has a market capitalization of $1.38 billion, a P/E ratio of 31.39 and a beta of 0.62. The company has a current ratio of 2.68, a quick ratio of 1.42 and a debt-to-equity ratio of 0.56. The business has a fifty day simple moving average of $34.81 and a two-hundred day simple moving average of $33.71.

TriMas (NASDAQ:TRS) last issued its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.57 by $0.04. TriMas had a net margin of 4.35% and a return on equity of 12.39%. The company had revenue of $269.26 million during the quarter, compared to analyst estimates of $262.05 million. During the same period last year, the business earned $0.43 EPS. TriMas’s quarterly revenue was up 17.4% compared to the same quarter last year. TriMas has set its FY 2025 guidance at 2.020-2.120 EPS. On average, equities analysts forecast that TriMas Corporation will post 1.69 earnings per share for the current fiscal year.

TriMas Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, November 13th. Investors of record on Thursday, November 6th were paid a $0.04 dividend. The ex-dividend date was Thursday, November 6th. This represents a $0.16 annualized dividend and a dividend yield of 0.5%. TriMas’s dividend payout ratio is presently 14.81%.

Analysts Set New Price Targets

Several brokerages recently issued reports on TRS. Wall Street Zen lowered shares of TriMas from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. KeyCorp decreased their target price on shares of TriMas from $45.00 to $38.00 and set an “overweight” rating on the stock in a research note on Thursday, November 13th. BWS Financial reiterated a “buy” rating and set a $45.00 target price on shares of TriMas in a report on Friday, December 5th. Zacks Research raised TriMas from a “hold” rating to a “strong-buy” rating in a research note on Friday, August 29th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of TriMas in a research note on Monday. One analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, TriMas currently has a consensus rating of “Buy” and an average target price of $41.50.

Insiders Place Their Bets

In related news, Director Jeffrey A. Fielkow acquired 2,000 shares of the stock in a transaction on Tuesday, November 11th. The stock was acquired at an average price of $31.46 per share, for a total transaction of $62,920.00. Following the completion of the purchase, the director owned 17,653 shares of the company’s stock, valued at $555,363.38. This represents a 12.78% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 14.20% of the stock is currently owned by company insiders.

About TriMas

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.